2389-60-8
2389-60-8
Chemical Structure
Cbz-Lys(Boc)-OH
- CAS No.: 2389-60-8
- Formula:C19H28N2O6
- Molecular Weight:380.44
IUPAC Name: N2-((benzyloxy)carbonyl)-N6-(tert-butoxycarbonyl)-L-lysine
InChIKey: DYSBKEOCHROEGX-HNNXBMFYSA-N
SMILES: O=C(O)[C@H](CCCCNC(OC(C)(C)C)=O)NC(OCC1=CC=CC=C1)=O
Biological Activity: Cbz-Lys (Boc)-OH is a protected Lysine derivative. Cbz-Lys (Boc)-OH can be used in the synthetic research of Prostasin inhibitors. Cbz-Lys (Boc)-OH can be applied to research related to cystic fibrosis[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cbz-Lys(Boc)-OH | 99.66% | Cbz-Lys (Boc)-OH is a protected Lysine derivative. Cbz-Lys (Boc)-OH can be used in the synthetic research of Prostasin inhibitors. Cbz-Lys (Boc)-OH can be applied to research related to cystic fibrosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Kim YB, et al. Imidazo[1,2-a]pyridine-based peptidomimetics as inhibitors of Akt. Bioorganic & medicinal chemistry letters. 2014 Oct 01;24(19):4650-4653. [Content Brief]
- [2]. Tully DC, et al. Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design. Bioorganic & medicinal chemistry letters. 2008 Nov 15;18(22):5895-9. [Content Brief]
